StudyID,Drug_Name,Sponsor_Type,COVID_Impact,No_Competing_Trial,No_SOC,CRO,CRO_Oper,CRO_Stat,CRO_DM,RBM
NCT01295827,Pembrolizumab,Industry,,,,,,,,
